| 11/17/2026 12:47 PM | Logos Global Management LP (1792126) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G/A | |
| 11/16/2026 8:53 PM | ADAR1 Capital Management, LLC (1940272) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G/A | |
| 11/16/2026 11:57 AM | Janus Henderson Group Ltd. (1274173) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G/A | |
| 11/16/2026 8:47 AM | AMERIPRISE FINANCIAL INC (820027) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G | |
| 11/16/2026 7:43 AM | RTW Fund Group GP, LLC (2147397) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G/A | |
| 11/13/2026 4:30 PM | Yarrow Bioscience (1566044) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 11/13/2026 3:56 PM | Nantahala Capital Management, LLC (1472322) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G/A | |
| 11/13/2026 6:52 AM | Yarrow Bioscience (1566044) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2026 6:07 AM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2026 3:01 PM | Yarrow Bioscience (1566044) Issuer Zeronda Tyler (1867033) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/30/2026 3:02 PM | Ryder Steven (1872868) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for YARW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Yarrow Bioscience and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/30/2026 3:02 PM | Frey Rebecca (2145132) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/30/2026 3:03 PM | Alford Rachael (2143892) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/30/2026 3:04 PM | Payton Lori (2144768) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2026 11:41 AM | Bellevue Group AG (1674546) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G | |
| 09/17/2026 3:57 PM | Invus Global Management, LLC (2005369) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G | |
| 09/14/2026 3:01 PM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2026 3:44 PM | Yarrow Bioscience (1566044) Filer | Form 424B5 | |
| 09/11/2026 3:52 PM | Yarrow Bioscience (1566044) Filer | Form 424B5 | |
| 09/10/2026 3:01 PM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/19/2026 11:15 PM | Yarrow Bioscience (1566044) Filer | Form EFFECT | |
| 08/14/2026 8:32 PM | ADAR1 Capital Management, LLC (1940272) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G | |
| 08/13/2026 3:03 PM | Yarrow Bioscience (1566044) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/13/2026 9:00 AM | Yarrow Bioscience (1566044) Subject Zhang Xiaofan (2140685) Filed by | Form SCHEDULE 13G/A | |
| 08/07/2026 6:51 PM | Logos Global Management LP (1792126) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G/A | |
| 08/07/2026 11:51 AM | Janus Henderson Group Ltd. (1274173) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G | |
| 08/05/2026 8:08 PM | ORBIMED ADVISORS LLC (1055951) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13D | |
| 08/04/2026 1:12 PM | Logos Global Management LP (1792126) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G | |
| 07/30/2026 3:01 PM | RTW Fund Group GP, LLC (2147397) Reporting WONG RODERICK (1493280) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/30/2026 3:03 PM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/30/2026 3:05 PM | RTW Fund Group GP, LLC (2147397) Reporting WONG RODERICK (1493280) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/30/2026 3:06 PM | RTW Fund Group GP, LLC (2147397) Filed by Yarrow Bioscience (1566044) Subject | Form SCHEDULE 13G | |
| 07/29/2026 8:00 PM | Frey Rebecca (2145132) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:03 PM | Ryder Steven (1872868) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:05 PM | Payton Lori (2144768) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:08 PM | Alford Rachael (2143892) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:11 PM | Hoerter Steven L. (1533451) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:15 PM | Lundberg Sven Ante (1682126) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:17 PM | Silverman Peter B. (1790314) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:20 PM | White William Richard (1778739) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:21 PM | Ashiya Mona (1794070) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Pentagon magnet restrictions take effect January 1, 2027 (Ad) A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production.
The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing.
The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027. Read the full breakdown of the proposed Army rare earth agreement and the company behind it. |
| 07/29/2026 8:26 PM | ORBIMED ADVISORS LLC (1055951) Reporting OrbiMed Capital GP X LLC (2140741) Reporting OrbiMed Genesis GP LLC (1808744) Reporting Yarrow Bioscience (1566044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/29/2026 8:33 PM | Yarrow Bioscience (1566044) Issuer Zeronda Tyler (1867033) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2026 8:36 PM | Ashiya Mona (1794070) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 7:14 AM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/17/2026 7:41 PM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/17/2026 8:54 AM | Yarrow Bioscience (1566044) Subject Zhang Xiaofan (2140685) Filed by | Form SCHEDULE 13G/A | |
| 07/14/2026 9:06 AM | Yarrow Bioscience (1566044) Subject Zhang Xiaofan (2140685) Filed by | Form SCHEDULE 13G/A | |
| 07/14/2026 7:12 AM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/14/2026 7:14 AM | Yarrow Bioscience (1566044) Subject | Form 425 | |
| 07/10/2026 7:06 AM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/10/2026 7:07 AM | Yarrow Bioscience (1566044) Subject | Form 425 | |
| 07/02/2026 7:05 PM | Domzalski David (1727794) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:05 PM | Harsch Mutya (1727809) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:05 PM | Stuart Iain (1727756) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 7:05 PM | Yarrow Bioscience (1566044) Issuer Zeronda Tyler (1867033) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 11:15 PM | Yarrow Bioscience (1566044) Filer | Form EFFECT | |
| 06/16/2026 8:45 AM | Yarrow Bioscience (1566044) Filer | Form ARS | |
| 06/15/2026 3:46 PM | Yarrow Bioscience (1566044) Filer | Form 424B3 | |
| 06/15/2026 1:24 PM | Yarrow Bioscience (1566044) Subject Zhang Xiaofan (2140685) Filed by | Form SCHEDULE 13G | |
| 06/03/2026 8:29 AM | Yarrow Bioscience (1566044) Filer | Form S-4/A | |
| 05/21/2026 4:00 PM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 3:04 PM | Yarrow Bioscience (1566044) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/28/2026 4:28 PM | Yarrow Bioscience (1566044) Filer | Form S-4/A | |
| 03/31/2026 4:28 PM | Yarrow Bioscience (1566044) Filer | Form S-4 Registration statement under Securities Act of 1933 | |
| 03/11/2026 3:57 PM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/27/2026 7:01 AM | Yarrow Bioscience (1566044) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 01/30/2026 3:10 PM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/30/2026 3:11 PM | Yarrow Bioscience (1566044) Subject | Form 425 | |
| 01/05/2026 7:30 AM | Harsch Mutya (1727809) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 7:30 AM | Stuart Iain (1727756) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 7:30 AM | Yarrow Bioscience (1566044) Issuer Zeronda Tyler (1867033) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 7:30 AM | Domzalski David (1727794) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 7:15 AM | Yarrow Bioscience (1566044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/17/2025 7:16 AM | Yarrow Bioscience (1566044) Subject | Form 425 | |
| 12/15/2025 3:15 PM | Basta Steven L (1417397) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:15 PM | LEPORE PATRICK G (1055404) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:15 PM | Little Elisabeth Sandoval (1632295) Reporting Yarrow Bioscience (1566044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |